
With deep experience in FDA regulatory law and health policy consulting, we advise patient advocates, global life science and innovative emerging companies on product approvals and regulatory reforms, drafting and enacting Federal legislation, and securing funding or creating new P3s...
Offering over 35 years of Federal health
policy and legislative insights, as former congressional committee staff, policy advisor, and leader of national FDA law and Federal affairs practices
Read the Milbank Quarterly essays on FDA in the Trump Administration or the Orphan Drug Act, the Health Affairs Forefront essays on HHS Secretary Kennedy and vaccines or mifepristone, or my quotes in the Financial TImes, AP, and trade press.

Keep up with FDA's changing regulatory priorities. Develop policy solutions and effective engagement strategies for FDA, HHS, NIH, CDC, ARPA-H and BARDA.

Our clients have included Fortune 500 and innovative early stage biopharmas, leading patient groups, coalitions, life science trade associations, and innovators in Europe, South Korea and Israel.

Our solutions are grounded in sound policy, a clear understanding of the law, and the best clinical evidence - helping advance public health for all.

If you need to work with CMS, secure a Federal contract, or lobby Congress, our trusted consulting partners are established experts in their domains.

Feel free to call or message with your health policy question. Let's discuss the issue and find some new approaches...
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.